Overview

Resveratrol, Cardiovascular Risk Markers And Cognitive Performance In Patients With Schizophrenia

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
Resveratrol supplementation may improve cardiovascular risk factors and cognitive parameters in patients with schizophrenia taking antipsychotics?
Phase:
Phase 2
Details
Lead Sponsor:
Federal University of Rio Grande do Sul
Collaborator:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Treatments:
Resveratrol